We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COMMITTEE SUGGESTS CFC ALBUTEROL INHALER PHASEOUT
COMMITTEE SUGGESTS CFC ALBUTEROL INHALER PHASEOUT
June 18, 2004
Chlorofluorocarbon (CFC)-propelled albuterol metered dose inhalers (MDIs) should be phased out by 2006, members of the FDA’s Pulmonary-Allergy Drugs Advisory Committee suggested in anticipation of the agency publishing a proposed rule on the matter.